Skip to main content
Clinical Trials/NCT04298580
NCT04298580
Unknown
Not Applicable

Randomized, Single-Blinded Study to Evaluate the Timing Effect of Ultrasound-Guided Paravertebral Block in Patients Undergoing Robotic Mitral Valve Repair Procedure

Cedars-Sinai Medical Center0 sites60 target enrollmentSeptember 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Nerve Block
Sponsor
Cedars-Sinai Medical Center
Enrollment
60
Primary Endpoint
Durations of ICU and hospitalization
Last Updated
5 years ago

Overview

Brief Summary

This study is to evaluate whether the administration of ultrasound-guided paravertebral block (PVB) after surgery would produce better postoperative pain control and fast postoperative recovery after Robotic cardiac surgery. Half of participants will receive PVB before surgery, while the other half will receive PVB at the end of surgery.

Detailed Description

Ultrasound-guided PVB (either before surgery, or after surgery) is the standard postoperative pain management for Robotic cardiac surgery. This technique is to inject local anesthetic (numb medication) around nerve to decrease pain. But the optimal time of PVB is unknown. The administration of PVB before surgery can help pain control during the surgery and after surgery. But the duration of PVB could be reduced because surgery itself can last 5-6 hrs. The PVB after surgery will not provide pain control during surgery, but may provide longer pain control after surgery, and may help participants faster recovery after surgery.

Registry
clinicaltrials.gov
Start Date
September 1, 2020
End Date
March 31, 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Manxu Zhao

Principal Investigator

Cedars-Sinai Medical Center

Eligibility Criteria

Inclusion Criteria

  • Age ≥ 18 yrs
  • Either gender

Exclusion Criteria

  • Refusal to participate in the study
  • Age\< 18 yrs
  • Contraindications to regional blockage including but not limited to:
  • Patient refusal to regional blockade
  • Infection at the site of needle insertion
  • Systemic infection
  • Bleeding diathesis or coagulopathy

Outcomes

Primary Outcomes

Durations of ICU and hospitalization

Time Frame: 2-6 days

Duration (days) of ICU stay, and duration of hospital stay

Secondary Outcomes

  • Pain intensity measure(2-3 days)

Similar Trials